Skip to main content
Watch Insiders
RPRX filings

Corporate insider profile

Marshall Urist Filing Activity

Latest reported as EVP, Research & Investments of Royalty Pharma plc (RPRX).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,950,041.96
Latest transaction
Jun 24, 2026

Affiliated corporations

Reported company relationships

RPRXLatest reported

Royalty Pharma plc

EVP, Research & Investments

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 24, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale9,098$55.18$502,067
May 20, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale13,684$52.75$721,838
May 14, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale13,684$53.06$726,137